SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Pharmaceuticals to showcase new, updated data on GBR 830

10 May 2018 Evaluate

Glenmark Pharmaceuticals will be presenting new and updated data on GBR 830 at the upcoming International Investigative Dermatology (IID) meeting in Orlando, Florida.

The GBR 830 presentations at IID 2018 include one oral presentation and three poster presentations on GBR 830, an investigational treatment for moderate-to-severe atopic dermatitis. The IID meeting occurs only once every five years and brings together top researchers from across the globe to further the understanding of skin biology and dermatologic disease.

Glenmark Pharmaceuticals is a global innovative pharmaceutical company with operations in more than 50 countries.

Glenmark Pharma Share Price

2364.35 -6.70 (-0.28%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×